SlideShare a Scribd company logo
1 of 16
C O R E Y D I L L A R D
Saccharomyces cerevisiae:
Providing Insight Into Human
Tumor Suppressor Genes
Saccharomyces cerevisiae
(Yeast)
 Model organism for
humans
 Eukaryotic
 Gene and Protein
homologs
 Quick replication
 Haploid or Diploid form
TEP1 (YNL128W)
 Saccharomyces cerevisiae homolog for
PTEN/MMAC1/TEP1
 Yeast strains deleted for TEP1:
 Show no phenotype in haploids
 Diploids exhibit resisitance to phosphatidylinositol-3-
phosphate kinase inhibitor
 Wortmannin
 Lithium ions (LY294002)
PTEN/MMAC1/TEP1
 PTEN
 Phosphatase and tensin homolog
 Tumor suppressor protein
 Modifies other proteins and fats by removing phosphate groups
 MMAC1
 Mutated in multiple advanced cancers
 TEP1
 Tensin-like phosphatase
PTEN/MMAC1/TEP1
 Health conditions associated with mutations:
 Bannayan-Riley-Ruvalcaba syndrome
 Formation of hamartomas and other tumors
 Cowden syndrome
 Formation of hamartomas and increased risk of developing breast,
thyroid, and endometrial cancer
 Proteus syndrome
 Asymmetric overgrowth of the bones, skin, and other tissues
 Cancers
 Prostate, endometrial, and melanoma
 Glioblastomas and astrocytomas
PTEN in PI3-Kinase Pathway
 The PI3-kinase pathway is essential for cell
metabolism, proliferation, cell-cycle progression, and
survival
 PTEN is responsible for directly inhibiting PIP3
 Unrestrained signaling can lead to lymphomas and
leukemia
Akt/PKB
 Serine/threonine protein
kinase
 Inactivates multiple
targets by
phosphorylation
 PIP3 and PI3-kinase
 Recruitment of Akt and
PDK1
 Akt and PDK1
 PH domain docking sites
PI3K/Akt Signaling Pathway
Resistance to PI3-Kinase Inhibitors
 Various concentrations
 Lithium ions
 Wortmannin
 Haploid
 Weak to no phenotype
 Diploid
 Strong phenotype
(resistance)
 Growth inhibition
Lifespan Determination
 Cells from liquid culture to plate
 Isolation of buds from mother cells
 Compare divisions between knockout
haploid/diploid strains
 Mean lifespan
 Is TEP1 responsible for aging process?
TEP1 in Sporulation
 Determine cells completing meiosis I and II
 Fluorescence microscopy
 DNA-specific dye, DAPI (4’, 6-diamidino-2-phenyl-indole)
 TEP1 absence effect?
 None on spore viability
 High amount of damaged asci and released spores in diploid
Sporulation/Fluorescence
Spore Wall Formation
 Dityrosine (fluorescent) during ascus maturation
 Component of spore wall
 UV light or fluorescence microscopy
 Mutant
 Accumulated earlier, final level lower
 Wild type
 Accumulated slower, final level higher
 Why?
 Cellular fractionation
Summary
 Yeast – Maturation of spore wall + meiotic cell
Human – Extracellular matrix + epithelial cell
 Carcinogenesis
 Alteration of pathways compensate for absence of
TEP1
 Possibly restore phosphatidylinositols to normal levels
 TEP1 is involved in the phosphatidylinositol pathway
in yeast
References
 "PI3K / Akt Signaling Pathway." Welcome to CST.
Ed. Michael Scheid. N.p., Sept. 2007. Web. 3 Nov.
2014.
 Heymont, Jennifer, Ludmilla Berenfeld, Jennifer
Collins, and Alexandra Kaganovich. "TEP1, the Yeast
Homolog of the Human Tumor Suppressor Gene
PTEN/MMCAC1/TEP, Is Linked to the
Phosphatidylinositol Pathway and Plays a Role in the
Developmental Process of Sporulation." PNAS 97.23
(2000): 12673-2677. Print
THANK YOU! QUESTIONS?

More Related Content

What's hot

mTOR: growth regulator involved in disease
mTOR: growth regulator involved in diseasemTOR: growth regulator involved in disease
mTOR: growth regulator involved in diseasedgotto
 
Tyrosinekinase inhibitors rahul
Tyrosinekinase inhibitors  rahulTyrosinekinase inhibitors  rahul
Tyrosinekinase inhibitors rahulRahul Sankar
 
Ernie ppt
Ernie pptErnie ppt
Ernie pptcbsua
 
Seminar- recent advances in apoptosis
Seminar- recent advances in apoptosisSeminar- recent advances in apoptosis
Seminar- recent advances in apoptosisEkta Jajodia
 
Akt (protein kinase)
Akt (protein kinase)Akt (protein kinase)
Akt (protein kinase)Amy Mehaboob
 
Onocogene and tumor suppressor genes
Onocogene and tumor suppressor genesOnocogene and tumor suppressor genes
Onocogene and tumor suppressor genes9596276530AMIN
 
5. tumor suppressor genes dr. sinhasan, mdzah
5. tumor suppressor genes  dr. sinhasan, mdzah5. tumor suppressor genes  dr. sinhasan, mdzah
5. tumor suppressor genes dr. sinhasan, mdzahkciapm
 
oncogenes and tumour supressor genes
oncogenes and tumour supressor genesoncogenes and tumour supressor genes
oncogenes and tumour supressor genesNivedha Vedhina
 
Apoptosis and cancer stem cell
Apoptosis and cancer stem cellApoptosis and cancer stem cell
Apoptosis and cancer stem cellAyush Kaundal
 
Novel Tyrosine Kinase Inhibitors for Ovarian Cancer
Novel Tyrosine Kinase Inhibitors for Ovarian CancerNovel Tyrosine Kinase Inhibitors for Ovarian Cancer
Novel Tyrosine Kinase Inhibitors for Ovarian CancerZuleika86
 
Epigenetic in Cancer
Epigenetic in CancerEpigenetic in Cancer
Epigenetic in CancerAbeer Ibrahim
 
Inhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipidInhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipidSaris Arango
 
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...dgotto
 

What's hot (19)

Apoptosis
Apoptosis Apoptosis
Apoptosis
 
mTOR: growth regulator involved in disease
mTOR: growth regulator involved in diseasemTOR: growth regulator involved in disease
mTOR: growth regulator involved in disease
 
Tyrosinekinase inhibitors rahul
Tyrosinekinase inhibitors  rahulTyrosinekinase inhibitors  rahul
Tyrosinekinase inhibitors rahul
 
Ernie ppt
Ernie pptErnie ppt
Ernie ppt
 
pI3K pathway
pI3K pathwaypI3K pathway
pI3K pathway
 
Microbiology:Tumor Suppressor Genes
Microbiology:Tumor Suppressor GenesMicrobiology:Tumor Suppressor Genes
Microbiology:Tumor Suppressor Genes
 
Seminar- recent advances in apoptosis
Seminar- recent advances in apoptosisSeminar- recent advances in apoptosis
Seminar- recent advances in apoptosis
 
Akt (protein kinase)
Akt (protein kinase)Akt (protein kinase)
Akt (protein kinase)
 
Onocogene and tumor suppressor genes
Onocogene and tumor suppressor genesOnocogene and tumor suppressor genes
Onocogene and tumor suppressor genes
 
5. tumor suppressor genes dr. sinhasan, mdzah
5. tumor suppressor genes  dr. sinhasan, mdzah5. tumor suppressor genes  dr. sinhasan, mdzah
5. tumor suppressor genes dr. sinhasan, mdzah
 
Cancer Pathways
Cancer PathwaysCancer Pathways
Cancer Pathways
 
oncogenes and tumour supressor genes
oncogenes and tumour supressor genesoncogenes and tumour supressor genes
oncogenes and tumour supressor genes
 
Apoptosis and cancer stem cell
Apoptosis and cancer stem cellApoptosis and cancer stem cell
Apoptosis and cancer stem cell
 
Novel Tyrosine Kinase Inhibitors for Ovarian Cancer
Novel Tyrosine Kinase Inhibitors for Ovarian CancerNovel Tyrosine Kinase Inhibitors for Ovarian Cancer
Novel Tyrosine Kinase Inhibitors for Ovarian Cancer
 
Epigenetic in Cancer
Epigenetic in CancerEpigenetic in Cancer
Epigenetic in Cancer
 
Inhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipidInhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipid
 
Cancer
CancerCancer
Cancer
 
Cancer genes
Cancer genesCancer genes
Cancer genes
 
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
 

Similar to Colloqium Presentation

Apoptosis continued
Apoptosis continuedApoptosis continued
Apoptosis continuedJyoti Sharma
 
Drug safety (1)
Drug safety (1)Drug safety (1)
Drug safety (1)drmcbansal
 
Molecular basis of aging and longevity
Molecular basis of aging and longevityMolecular basis of aging and longevity
Molecular basis of aging and longevityGualbertoJrLantaya
 
Models of Human Diseases Conference (2010) Tetrahymena model by Dr. R. Pearl...
Models of Human Diseases Conference (2010)  Tetrahymena model by Dr. R. Pearl...Models of Human Diseases Conference (2010)  Tetrahymena model by Dr. R. Pearl...
Models of Human Diseases Conference (2010) Tetrahymena model by Dr. R. Pearl...Medical Education Advising
 
A Study On Meeting Receptor
A Study On Meeting ReceptorA Study On Meeting Receptor
A Study On Meeting ReceptorStephanie Clark
 
First aid for usmle step 1 with uworld and nbme notes sample
First aid for usmle step 1 with uworld and nbme notes sampleFirst aid for usmle step 1 with uworld and nbme notes sample
First aid for usmle step 1 with uworld and nbme notes sampleusmlematerialsnet
 
Class anticancer drugs
Class anticancer drugsClass anticancer drugs
Class anticancer drugsRaghu Prasada
 
Human Papiiloma Virus
Human Papiiloma VirusHuman Papiiloma Virus
Human Papiiloma Virusahmedicine
 
Surveying double-side effects of hippo pathway in regeneration.pptx
Surveying double-side effects of hippo pathway in regeneration.pptxSurveying double-side effects of hippo pathway in regeneration.pptx
Surveying double-side effects of hippo pathway in regeneration.pptxSimindokht1
 
Free Radical injury and acute phase reactants
Free Radical injury and acute phase reactantsFree Radical injury and acute phase reactants
Free Radical injury and acute phase reactantsDr Siddartha
 
GENE Expression TARGETED THERAPY.pdf
GENE Expression  TARGETED THERAPY.pdfGENE Expression  TARGETED THERAPY.pdf
GENE Expression TARGETED THERAPY.pdfmohieeldien elsayed
 
MON 2011 - Slide 16 - M.R. Alison - Joint medics and nurses spotlight session...
MON 2011 - Slide 16 - M.R. Alison - Joint medics and nurses spotlight session...MON 2011 - Slide 16 - M.R. Alison - Joint medics and nurses spotlight session...
MON 2011 - Slide 16 - M.R. Alison - Joint medics and nurses spotlight session...European School of Oncology
 
Reproductive Toxicology
Reproductive ToxicologyReproductive Toxicology
Reproductive Toxicologyelegacki
 
cellularageing-200601173158 (1).pdf
cellularageing-200601173158 (1).pdfcellularageing-200601173158 (1).pdf
cellularageing-200601173158 (1).pdfNoName193715
 

Similar to Colloqium Presentation (20)

Apoptosis continued
Apoptosis continuedApoptosis continued
Apoptosis continued
 
Drug safety (1)
Drug safety (1)Drug safety (1)
Drug safety (1)
 
Molecular basis of aging and longevity
Molecular basis of aging and longevityMolecular basis of aging and longevity
Molecular basis of aging and longevity
 
Tissue Injury
Tissue InjuryTissue Injury
Tissue Injury
 
Models of Human Diseases Conference (2010) Tetrahymena model by Dr. R. Pearl...
Models of Human Diseases Conference (2010)  Tetrahymena model by Dr. R. Pearl...Models of Human Diseases Conference (2010)  Tetrahymena model by Dr. R. Pearl...
Models of Human Diseases Conference (2010) Tetrahymena model by Dr. R. Pearl...
 
A Study On Meeting Receptor
A Study On Meeting ReceptorA Study On Meeting Receptor
A Study On Meeting Receptor
 
First aid for usmle step 1 with uworld and nbme notes sample
First aid for usmle step 1 with uworld and nbme notes sampleFirst aid for usmle step 1 with uworld and nbme notes sample
First aid for usmle step 1 with uworld and nbme notes sample
 
Class anticancer drugs
Class anticancer drugsClass anticancer drugs
Class anticancer drugs
 
Human Papiiloma Virus
Human Papiiloma VirusHuman Papiiloma Virus
Human Papiiloma Virus
 
Surveying double-side effects of hippo pathway in regeneration.pptx
Surveying double-side effects of hippo pathway in regeneration.pptxSurveying double-side effects of hippo pathway in regeneration.pptx
Surveying double-side effects of hippo pathway in regeneration.pptx
 
Free Radical injury and acute phase reactants
Free Radical injury and acute phase reactantsFree Radical injury and acute phase reactants
Free Radical injury and acute phase reactants
 
Cancer
CancerCancer
Cancer
 
ONCOGENE AND TUMOUR SUPPRESSOR GENE
ONCOGENE AND TUMOUR SUPPRESSOR GENEONCOGENE AND TUMOUR SUPPRESSOR GENE
ONCOGENE AND TUMOUR SUPPRESSOR GENE
 
GENE Expression TARGETED THERAPY.pdf
GENE Expression  TARGETED THERAPY.pdfGENE Expression  TARGETED THERAPY.pdf
GENE Expression TARGETED THERAPY.pdf
 
MCC 2011 - Slide 4
MCC 2011 - Slide 4MCC 2011 - Slide 4
MCC 2011 - Slide 4
 
1 Lactaptin
1 Lactaptin1 Lactaptin
1 Lactaptin
 
MON 2011 - Slide 16 - M.R. Alison - Joint medics and nurses spotlight session...
MON 2011 - Slide 16 - M.R. Alison - Joint medics and nurses spotlight session...MON 2011 - Slide 16 - M.R. Alison - Joint medics and nurses spotlight session...
MON 2011 - Slide 16 - M.R. Alison - Joint medics and nurses spotlight session...
 
Reproductive Toxicology
Reproductive ToxicologyReproductive Toxicology
Reproductive Toxicology
 
cellularageing-200601173158 (1).pdf
cellularageing-200601173158 (1).pdfcellularageing-200601173158 (1).pdf
cellularageing-200601173158 (1).pdf
 
Cellular ageing
Cellular ageingCellular ageing
Cellular ageing
 

Colloqium Presentation

  • 1. C O R E Y D I L L A R D Saccharomyces cerevisiae: Providing Insight Into Human Tumor Suppressor Genes
  • 2. Saccharomyces cerevisiae (Yeast)  Model organism for humans  Eukaryotic  Gene and Protein homologs  Quick replication  Haploid or Diploid form
  • 3. TEP1 (YNL128W)  Saccharomyces cerevisiae homolog for PTEN/MMAC1/TEP1  Yeast strains deleted for TEP1:  Show no phenotype in haploids  Diploids exhibit resisitance to phosphatidylinositol-3- phosphate kinase inhibitor  Wortmannin  Lithium ions (LY294002)
  • 4. PTEN/MMAC1/TEP1  PTEN  Phosphatase and tensin homolog  Tumor suppressor protein  Modifies other proteins and fats by removing phosphate groups  MMAC1  Mutated in multiple advanced cancers  TEP1  Tensin-like phosphatase
  • 5. PTEN/MMAC1/TEP1  Health conditions associated with mutations:  Bannayan-Riley-Ruvalcaba syndrome  Formation of hamartomas and other tumors  Cowden syndrome  Formation of hamartomas and increased risk of developing breast, thyroid, and endometrial cancer  Proteus syndrome  Asymmetric overgrowth of the bones, skin, and other tissues  Cancers  Prostate, endometrial, and melanoma  Glioblastomas and astrocytomas
  • 6. PTEN in PI3-Kinase Pathway  The PI3-kinase pathway is essential for cell metabolism, proliferation, cell-cycle progression, and survival  PTEN is responsible for directly inhibiting PIP3  Unrestrained signaling can lead to lymphomas and leukemia
  • 7. Akt/PKB  Serine/threonine protein kinase  Inactivates multiple targets by phosphorylation  PIP3 and PI3-kinase  Recruitment of Akt and PDK1  Akt and PDK1  PH domain docking sites
  • 9. Resistance to PI3-Kinase Inhibitors  Various concentrations  Lithium ions  Wortmannin  Haploid  Weak to no phenotype  Diploid  Strong phenotype (resistance)  Growth inhibition
  • 10. Lifespan Determination  Cells from liquid culture to plate  Isolation of buds from mother cells  Compare divisions between knockout haploid/diploid strains  Mean lifespan  Is TEP1 responsible for aging process?
  • 11. TEP1 in Sporulation  Determine cells completing meiosis I and II  Fluorescence microscopy  DNA-specific dye, DAPI (4’, 6-diamidino-2-phenyl-indole)  TEP1 absence effect?  None on spore viability  High amount of damaged asci and released spores in diploid
  • 13. Spore Wall Formation  Dityrosine (fluorescent) during ascus maturation  Component of spore wall  UV light or fluorescence microscopy  Mutant  Accumulated earlier, final level lower  Wild type  Accumulated slower, final level higher  Why?  Cellular fractionation
  • 14. Summary  Yeast – Maturation of spore wall + meiotic cell Human – Extracellular matrix + epithelial cell  Carcinogenesis  Alteration of pathways compensate for absence of TEP1  Possibly restore phosphatidylinositols to normal levels  TEP1 is involved in the phosphatidylinositol pathway in yeast
  • 15. References  "PI3K / Akt Signaling Pathway." Welcome to CST. Ed. Michael Scheid. N.p., Sept. 2007. Web. 3 Nov. 2014.  Heymont, Jennifer, Ludmilla Berenfeld, Jennifer Collins, and Alexandra Kaganovich. "TEP1, the Yeast Homolog of the Human Tumor Suppressor Gene PTEN/MMCAC1/TEP, Is Linked to the Phosphatidylinositol Pathway and Plays a Role in the Developmental Process of Sporulation." PNAS 97.23 (2000): 12673-2677. Print